Skip to main content
Recall Canary
Sodium Iodide (I-131) Therapeutic Oral Solution
← Back to all recalls
DRUG RECALLMODERATE

Sodium Iodide (I-131) Therapeutic Oral Solution

Radnostix is recalling Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter.

What to do

Check your inventory for the affected order numbers and vial sizes. Do not use the product if it contains particulate matter and contact the manufacturer for return instructions.

Posted
Updated
Recall No.
D-0389-2026
Agency
Firm
Radnostix
Recall ID
98470
Status
ONGOING

Why it was recalled

Radnostix is recalling specific orders of Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter identified during production. This recall affects multiple vial sizes and order numbers distributed nationwide in the USA and Puerto Rico.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.

Recall #
D-0389-2026

Where it was sold

Distributed nationwide.

Other recent recalls from Radnostix

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-11 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification